Targeted Medical Pharma (OTCMKTS:TRGM) Stock Passes Above 50-Day Moving Average – Here’s What Happened

Shares of Targeted Medical Pharma, Inc. (OTCMKTS:TRGMGet Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Targeted Medical Pharma shares last traded at $0.00, with a volume of 0 shares trading hands.

Targeted Medical Pharma Price Performance

About Targeted Medical Pharma

(Get Free Report)

Targeted Medical Pharma, Inc, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy.

Further Reading

Receive News & Ratings for Targeted Medical Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Targeted Medical Pharma and related companies with MarketBeat.com's FREE daily email newsletter.